Simplified equity change report (Sano Investment-updated version)
Simplified equity change report (Chuanfa Investment)
Announcement on the progress of the controlling shareholder\'s proposed agreement to transfer part of the company\'s shares
Shengnuo Biotech: Announcement on the signing of a major contract for daily operation by a wholly-owned subsidiary
Announcement on the signing of a major contract for daily operation by a wholly-owned subsidiary
Voluntary Disclosure Notice on Signing Overseas “Investment Cooperation Agreements”
Announcement on plans for shareholders holding 5% or more of the shares to reduce their holdings
Simplified Equity Change Report (Chuanfa Relief Fund)
Simplified equity change report (Sano Investment)
An indicative announcement regarding changes in the controlling shareholder\'s intention to transfer part of the company\'s shares and interests by agreement
Minsheng Securities Co., Ltd.'s continuous supervision and follow-up report on the Chengdu Shengnuo Biotechnology Co., Ltd.'s 2024 semi-annual report.
Chengdu Shengnuo Biotechnology Co., Ltd. Investor Relations Activity Record Form 2024-03
Investor relations activity record of Chengdu Shengnuo Biotechnology Co., Ltd. 2024-02
Announcement Regarding the Holding of the 2024 Semi-Annual Performance Briefing.
Half-year report for the year 2024.
Semi-annual evaluation report on the special action plan for quality improvement and efficiency increase of the company's return in 2024.
Summary of Half-Year Report in 2024.
Announcement of the resolution of the 22nd meeting of the fourth board of directors.
Announcement of Resolutions of the 21st Meeting of the Fourth Supervisory Board.
Legal Opinion of Junlan Law Firm Shanghai regarding Adjustments, Cancellation, and Attribution of Restricted Stock Incentive Plan Award Prices for Chengdu Shengnuo Biotechnology Co., Ltd. in 2023.
No Data
No Data